evolcSign inStart free
Menu

Stem Genomics

Genomic stability and cell identity testing for research and biotech labs working on human stem cells

Grabels, FranceFounded 2018stemgenomics.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-02

About Stem Genomics

Stem Genomics is a French biotech company that develops and performs genomic stability and identity testing for human stem cells. Its flagship product is iCS-digital PSC, a digital PCR-based assay for in-process genomic stability testing of human pluripotent stem cells. Other services include karyotyping, G-banding, STR cell line authentication, mycoplasma detection, pluripotency testing, next-generation sequencing assays and customised assays.

Customers are research scientists and organisations working on human stem cells, from academic institutions to biotech companies and core facilities. The company sells testing services per assay, and also offers a one-stop-shop package combining digital karyotyping, G-banding, mycoplasma detection, cell authentication and pluripotency testing.

Stem Genomics was founded in 2018 as a spin-out of the Institute for Regenerative Medicine & Biotherapy (IRMB) in Montpellier, co-founded by Prof. John de Vos and Dr. Said Assou. It operates laboratories in Montpellier, France, and in Durham, North Carolina, where it serves North American clients. The company is part of the Clean Cells group, which offers GMP release testing and cell banking.

Product: iCS-digital PSC digital PCR assay for genomic stability of human pluripotent stem cells, plus karyotyping, STR authentication, mycoplasma and pluripotency testing.

Jobs at Stem Genomics

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Stemcell Technologies

    Cell culture products, instruments and research services for life science researchers worldwide
    Saint-Egreve, FranceBiotech & pharmaFounded 1998
    New on Evolc

  • Substipharm

    Develops and supplies medicines and vaccines for pharmaceutical partners and patients worldwide
    Paris, FranceBiotech & pharmaFounded 2004
    New on Evolc

  • Tedis

    Pharmaceutical wholesale distributor linking laboratories with pharmacies and hospitals in France and export markets in Africa and Asia
    FranceBiotech & pharma1 open job
    New on EvolcSalary transparent

  • Thea Open Innovation

    Ophthalmology innovation partnerships and investment for startups, researchers and companies developing eye-care treatments
    Clermont-Ferrand, FranceBiotech & pharmaFounded 2018
    New on Evolc

  • Theravectys

    Lentiviral vector vaccine candidates for cancers and chronic infectious diseases, developed with Institut Pasteur
    Evry-Courcouronnes, FranceBiotech & pharmaFounded 2005
    New on Evolc

  • Tissium

    Biomorphic programmable polymers for tissue reconstruction in surgery, developed for medtech and surgical use
    Paris, FranceBiotech & pharmaFounded 20134 open jobs
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Backend

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

CRM & customer data

  • HubSpotHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Google reCAPTCHAHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.